Physician profile
Tracy Dillingham
NPI 1508020777
$750.26
in general payments reported to CMS, 2019-2025
9 companies · $65.71 in 2025
The $65.71 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $152 · 2022: $110 · 2023: $36.00 · 2024: $387 · 2025: $65.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $488.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $459.62 | 2021-2025 | Descovy |
| Coopersurgical, INC. | $76.96 | 2021-2024 | Paragard T 380a, Paragard T 380a |
| Viiv Healthcare Company | $56.70 | 2022-2025 | Apretude |
| Organon LLC | $43.65 | 2021-2024 | |
| Mylan Pharmaceuticals INC. | $35.97 | 2021 | |
| Agile Therapeutics, INC. | $35.83 | 2021-2022 | |
| Abbvie INC. | $15.68 | 2021 | |
| Avion Pharmaceuticals | $14.04 | 2021 | |
| Antares Pharma, INC. | $11.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Dillingham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.